Novo Nordisk A/S, Apollo Global Management, and BlackRock are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies that are expected to grow their revenues and earnings at an above-average rate compared to the overall market. Investors in growth stocks typically seek capital appreciation rather than dividend income, since these companies often reinvest profits back into expansion and new projects. Because they rely on future performance, growth stocks can be more volatile and carry higher risk, but they also offer the potential for significant returns if the companies meet or exceed growth expectations. These companies had the highest dollar trading volume of any Growth stocks within the last several days.
Novo Nordisk A/S (NVO)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Novo Nordisk A/S stock traded up $1.01 during trading hours on Wednesday, hitting $69.21. The stock had a trading volume of 5,344,051 shares, compared to its average volume of 6,633,031. Novo Nordisk A/S has a 1-year low of $57.00 and a 1-year high of $148.15. The stock has a market capitalization of $310.56 billion, a price-to-earnings ratio of 21.06, a PEG ratio of 0.90 and a beta of 0.65. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.74 and a quick ratio of 0.55. The stock's fifty day moving average is $67.00 and its two-hundred day moving average is $83.76.
Read Our Latest Research Report on NVO
Apollo Global Management (APO)
Apollo Global Management, Inc. is a private equity firm specializing in investments in credit, private equity, infrastructure, secondaries and real estate markets. The firm prefers to invest in private and public markets. The firm's private equity investments include traditional buyouts, recapitalization, distressed buyouts and debt investments in real estate, corporate partner buyouts, distressed asset, corporate carve-outs, middle market, growth, venture capital, turnaround, bridge, corporate restructuring, special situation, acquisition, and industry consolidation transactions.
Shares of NYSE APO traded down $5.45 during trading on Wednesday, reaching $133.84. The company had a trading volume of 1,939,534 shares, compared to its average volume of 3,910,709. The stock has a market capitalization of $76.35 billion, a PE ratio of 18.34, a price-to-earnings-growth ratio of 1.17 and a beta of 1.67. Apollo Global Management has a twelve month low of $95.11 and a twelve month high of $189.49. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.33. The stock has a 50-day moving average price of $133.29 and a two-hundred day moving average price of $152.49.
Read Our Latest Research Report on APO
BlackRock (BLK)
BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.
Shares of NYSE BLK traded down $9.15 during midday trading on Wednesday, reaching $988.56. 202,421 shares of the stock were exchanged, compared to its average volume of 690,212. BlackRock has a 52-week low of $752.30 and a 52-week high of $1,084.22. The stock has a 50 day moving average price of $919.68 and a 200-day moving average price of $978.24. The company has a current ratio of 5.23, a quick ratio of 5.23 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $153.15 billion, a P/E ratio of 23.58, a P/E/G ratio of 1.90 and a beta of 1.41.
Read Our Latest Research Report on BLK
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Novo Nordisk A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.
While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
